Risk factors for invasive aspergillosis in living donor liver transplant recipients

Liver Transpl. 2007 Apr;13(4):566-70. doi: 10.1002/lt.21099.

Abstract

Invasive aspergillosis (IA) is a severe complication of liver transplantation. Risk factors for IA after deceased donor liver transplantation (DDLT) have been presented in several reports, but are not well established for living donor liver transplant recipients. Here, a retrospective case-control study was performed. Five cases with IA were investigated after living donor liver transplantation (LDLT) between January 1999 and December 2002 at Kyoto University Hospital. For comparison, living donor liver transplant recipients without IA were taken as controls. These patients had undergone LDLT 1 month before or after each IA case and had the same survival times as the latter. We evaluated the clinical and laboratory findings for both groups up until their demise. Patients with IA after LDLT had a very poor prognosis. By univariate analysis, risk factors for IA were preoperative intensive care unit stay (P = 0.02) and preoperative steroid administration (P = 0.02). Preoperative steroid administration for fulminant hepatitis possibly predisposed to the development of IA after LDLT.

MeSH terms

  • Adult
  • Amphotericin B / therapeutic use
  • Anti-Bacterial Agents / therapeutic use
  • Aspergillosis / epidemiology*
  • Aspergillosis / pathology*
  • Aspergillosis / prevention & control
  • Bacterial Infections / prevention & control
  • Cephalosporins / therapeutic use
  • Female
  • Humans
  • Immunosuppression Therapy
  • Liver Cirrhosis / surgery
  • Liver Transplantation / adverse effects*
  • Liver Transplantation / immunology*
  • Liver Transplantation / pathology
  • Living Donors*
  • Male
  • Middle Aged
  • Postoperative Complications / microbiology*
  • Postoperative Complications / prevention & control
  • Retrospective Studies
  • Risk Factors

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • Amphotericin B
  • flomoxef